Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
List of Publications please visit here . Your qualifications should include: · PhD or M.D. Expertise in using mouse models to study metabolic diseases is preferred. · Extensive experience
-
blots, tissue culture, etc.) will be considered. Please send your CV, a letter of interest and a list of three references per email to Dr. Xu Yu (xyu@mgh.harvard.edu) or Dr. Mathias Lichterfeld
-
education from other countries than Norway must enclose witnessed diplomas in both the original language and authorized translations) and documentation of submitted doctoral thesis Complete list
-
) a cover letter describing current and future research, (2) a curriculum vitae, and (3) a list of three references to Dr. Wenyi Wang at wwang7@mdanderson.org . Application Deadline: 07/31/2025 Email of
-
The Institute of Physical Chemistry PAS (IChF), one of Poland’s top-ranked research institutes, invites applications for 20 Postdoctoral Fellow positions within the research training programme
-
. Applications, accompanied by a cover letter stating their research interests, detailed curriculum vitae including a list of your publications and the names of three potential references, should be directed
-
and innovation (R&I) ecosystem. This is a unique opportunity to establish or expand your research programme in the UK, collaborate with world-class researchers, and contribute to national and global
-
Fellowship Program supports outstanding early-career scientists and engineers from around the world. Fellows receive funding to pursue independent, cutting-edge research at KAUST for three years. Selection is
-
Training Group (RTG) “Activation of anti-Microbial Effectors (ACME)” (coordinator: Dirk Schlüter, Hannover) funded by the German Research Foundation. The central aim of the program is to give highly
-
August 2025 Background To create and contribute to the creation of knowledge by undertaking advanced analysis and validation experiments within the MRC BioFlare research programme: Although outcomes in RA